the Melanoma Institute of Australia
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
How Richard Scolyer made his mark in melanoma research
How Richard Scolyer made his mark in melanoma research Tue 9 Jun 2026 at 4:57am Richard Scolyer, the renowned Australian pathologist who died on Sunday at the age of 59, was instrumental in lowering melanoma deaths across the country. "Whatever happens, I feel like there will be a legacy from what Georgina, our team and I have tried to do," the former Australian of the Year wrote in his 2024 memoir, Brainstorm. Through consultation on external specimens, with diagnostic and classification...
'What a legacy': Pioneering researcher Richard Scolyer dies aged 59
Professor Richard Scolyer dies aged 59 leaving behind legacy of revolutionary brain cancer research Mon 8 Jun 2026 at 12:06am Former Australian of the Year Professor Richard Scolyer has died aged 59 after fighting the "worst of the worst brain cancers". His legacy: fast-tracking revolutionary cancer treatment by volunteering to be "patient zero" in a radical approach to treating his tumour. Scolyer fought the aggressive brain cancer for almost three years, defying the terrible survival odds.
Pioneering cancer specialist who became test case for world-first experimental treatment dies
Pioneering cancer specialist who became test case for world-first experimental treatment dies Prof Richard Scolyer’s groundbreaking work on immunotherapy revolutionised treatment of advanced melanoma - Bookmark - CommentsGo to comments Richard Scolyer, the pioneering Australian cancer specialist who became a test case for an experimental brain tumour treatment, died on Sunday night. His death prompted a wave of tributes for his transformative work in melanoma care. Scolyer, pathologist and...
Richard Scolyer Has Died
Australian doctor who underwent world-first brain tumour treatment dies Pioneering Australian doctor Richard Scolyer has died, three years after being diagnosed with an aggressive brain tumour. Scolyer, 59, made global headlines for his decision to undergo a risky world-first experimental treatment for his glioblastoma at the hands of his friend Professor Georgina Long - based on the pair's own scientific breakthroughs in skin cancer. Their work on advanced melanoma - once a death sentence -...